Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Mental Health & Behavioral Research
What is the purpose of this trial?
The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.
- Ages21 - 65 years
- Trial withPfeiffer Research Foundation
- Start Date05/31/2016
- End Date12/30/2016
- Last Updated04/05/2019
- Study HIC#1504015604